CLL Society's October 10th Virtual Global Patient Educational Forum, featuring Dr. John Byrd speaking on Clinical Trials! While Dr. John Byrd is well known for his clinical trials that have brought ground-breaking drugs to CLL and other blood cancers, he is equally well respected for always PUTTING PATIENTS FIRST in the DESIGN of any clinical trial. Dr. John Byrd will be there! You should be too! Register now: cllsociety.org/cll-societys...
CLL Society's October 10th Virtual Global Pati... - CLL Support
CLL Society's October 10th Virtual Global Patient Educational Forum, featuring Dr. John Byrd speaking on Clinical Trials!
Written by
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...
6 Replies
•
Outstanding!
Looking forward to this.
JM
Me too. Lots of work
Hope you are getting R/R and smelling roses in addition to all the progress.
Mostly smelling the smoke from the wildfires. Wearing a N95 mask to protect against particulate matter more than COVID in the backyard. Air quality is terrible in Los Angeles County
I know about the smoke. It is blowing into Montana and settling into our 5 valley area to the point that visibility is less than a mile.
Hope we get some moisture soon.
Not what you're looking for?
You may also like...
CLL Society & Clinical Care Options created a Patient Decision Support Tool
The CLL Society + Clinical Care Options created this Clinical Care Options Interactive Decision...
Some CLL clinical trials insist that patients have multiple CT scans. Every test should have a reason.
Cancer Patients Enrolled in Clinical Trials by Board member Bob Levis. Some CLL clinical trials...
End of suspense! Here is Dr. Koffman's ASCO 2020 \"Top Pick\" #1!
untreated patients with chronic lymphocytic leukemia (CLL)....
Worried About Going Back to Work?
friends. Smart Patients Get Smarty Care!™ https://cllsociety.org/2020/08/cll-societys-official-state
Clinical Trials studying COVID-19 vaccines in CLL: Some have begun/ others are coming!
CLL Society inquiring as to whether there are clinical trials studying CLL patients' response to the